Stocks to sell

Whether you’re risk-inclined or not, Tilray Brands (NASDAQ:TLRY) isn’t a promising investment as a cannabis stock, let alone an alcohol play.  The company has made some moves within the alcohol sector,which I’ll get to in a minute, but its core business continues to underperform. The company’s recent earnings reinforce the view that this is likely

With Lucid Group (NASDAQ:LCID) shares slumping back to their 52-week low, plenty are curious whether LCID stock could soon make a comeback. This is due largely to LCID’s high short interest. In the eyes of risk-hungry traders, this factor points to an increased potential for a “short squeeze,” or a big run-up in shares caused

So far this month, Mullen Automotive (NASDAQ:MULN) has popped back on the radars of many investors. A big reason for this is several major developments directly related to MULN stock. These include announced progress with some of the early-stage electric vehicle maker’s growth efforts. A reverse-stock split, which will enable Mullen to keep its Nasdaq

If any company is a darling on Wall Street in 2023, it’s definitely Nvidia (NASDAQ:NVDA). Analysts scrambled to lift their ratings and price targets on NVDA stock after its spectacular rally this year. Now, a call for clear-minded thinking is needed as a major near-term event could shut the party down. There’s no disputing that Nvidia

When a company issues a quarterly press release, typically it will put a positive spin on the company’s recent performance. That’s fine, but it means that investors should view Plug Power’s (NASDAQ:PLUG) latest earnings letter with a skeptical eye. After delving into the data, financial traders should seriously think about avoiding PLUG stock. The point

Dividend stocks have become investors’ favorites in recent months. Tech turbulence and high-interest rates combined to make high-yield stocks an alternative to riskier equities while still beating the yield on fixed-income investments like treasuries. Unfortunately, many investors chase the bottom-line yield stat without looking too closely into the underlying company. Dividend stocks are usually seen

I’ll start by noting that I’m by no means a critic of the cryptocurrency market in general – although some cryptos I believe investors should sell. The promise of decentralizing authority connected to finance and money is as appealing to me as it’s ever been. The more one learns about traditional finance the more apparent

If you are a public equities investor betting on the digital economy, semiconductor stocks would have to be in your portfolio. Semiconductors are tiny electronic devices powering everything from our smartphones and personal computers to cars and commercial airplanes. If you take any run-of-the-mill semiconductor exchange-traded fund (ETF), say, the iShares Semiconductor ETF (NASDAQ:SOXX), many

There’s been plenty of talk about a recession that hasn’t arrived. Although the recession talks have been around for a few years, you can only kick that can down the road so far before it comes full circle. The macroeconomic atmosphere is, to put it bluntly, horrible. Student loan payments will resume in September during

It has been a rough past couple of years for Tilray Brands (NASDAQ:TLRY), but more recently, things have started to look up for TLRY stock. Last month, shares in the Canada-based cannabis company began to rally again, on the heels of a well-received quarterly earnings release. Last week, shares spiked in price yet again, except

Investors seeking defensive exposure in this market may turn their attention to mining socks. These companies, involved in locating, extracting, and processing valuable minerals vital for global industries, play an essential role as a growth engine for the global economy. Without various important base metals, entire industries wouldn’t be possible. Indeed, these companies may be

Investors who’ve dipped their toe into the waters of biotech stocks know that the chances of these stocks crashing and burning is certainly higher than with most sectors. Failure is incredibly common for firms that engage in the development of pharmaceuticals. High costs and long product development timelines combine to produce spectacular failures rates, pretty

By no means is this discussion about meme stocks to sell an indication that you should avoid the sector altogether. Sometimes, it’s good to just have fun (responsibly, of course) in the market. Ultimately, you never know if that wild contrarian wager might turn into something substantive. That, of course, is the main temptation of

As much as I love good dividend stocks, I have very little patience for F-rated dividend stocks that do nothing but drag your portfolio down. As an investor, you deserve better! A great dividend stock can make all the difference in your portfolio. By reinvesting dividends, growth investors can increase their positions and investing power

The U.S. equity valuations continue their remarkable trend upward, well beyond anyone’s expectations in 2023. The major indices appreciated amid expectations of a soft landing for the economy as the Federal Reserve battles inflation. While inflation still sits above the Federal Reserve’s target, it is well below where it was 12 months ago. However, despite

For a hot minute, Wall Street loved electric vehicle (EV) battery technology company QuantumScape (NYSE:QS). Then, financial traders turned against the company and QS stock quickly coughed up its gains. Frankly, it’s just too risky to invest in QuantumScape now. Don’t get the wrong idea. The investing community is fickle, and any stock is susceptible

With pharmaceutical companies, it’s all about the pipeline of new medications. Drugmakers, and their pharma stocks, are judged based on sales of current medications and potential sales of future prescriptions. Analysts and investors alike are always on the lookout for the next blockbuster drug. This helps to explain why the stocks of pharmaceutical companies with

It’s the height of summer vacation season, and the stock market is taking a breather after its major rally earlier in the year. For active traders, much of the excitement has moved to penny stocks, with many low-priced equities making huge moves in recent weeks. Investors should avoid the urge to go plunging too aggressively

Although speculative enterprises tend to draw in a loyal band of followers, certain circumstances call for decisive action, as these small-cap stocks to avoid in August confirms. Nobody wants to be the guy or gal throwing in the towel. However, you can’t ignore clear signs of trouble. Certainly, just because warning signs pop up doesn’t mean

Investing in growth stocks can be risky, especially for those migrating into new markets or turnaround ventures. Personally, I’ve experienced losses from such endeavors. Amid rising interest rates, caution is advised for overpriced growth stocks. Despite recent declines, their valuations remain risky. Two factors contribute to their potential downfall: further interest rate hikes and underwhelming